But any experienced investor also knows that talk
Post# of 30028
Posted On: 12/02/2014 3:55:58 PM
Re: biotechexpert #12233
Quote:So why have some of our "experienced" investors here been so concerned with competition from the media attention over AD blood tests over the past year, when these tests are clearly years away from commercialization and most haven't even begun clinical trials yet?
But any experienced investor also knows that talk is cheap especially in the biotech space.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼